Results 51 to 60 of about 1,205,120 (277)

Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024

open access: yesEurosurveillance
We describe the genetic characteristics of a fusidic acid- and meticillin-resistant Staphylococcus aureus (MRSA) clone widespread in Europe, based on whole genome sequences from 317 isolates.
Andreas Petersen
doaj   +1 more source

The Picture of Nobody: Shakespeare’s anti-authorship

open access: yesAuthorship, 2014
"The Picture of Nobody" posits that Shakespeare's birth as an author in print was “aborted” by strategies of absence that avoided institutionalized forms of authorial representation.
Jasper Schelstraete
doaj   +2 more sources

Cyber-pseudepigraphy: A New Challenge for Higher Education Policy and Management [PDF]

open access: yes, 2004
There is no lack of critical literature dealing with cyber-plagiarism and the implications for assessment in higher education. The practice of the selling of academic papers through the Internet is generally included under the category of plagiarism ...
Anderson GL   +3 more
core   +2 more sources

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

Autochthonous transmission of extensively drug-resistant Neisseria gonorrhoeae in Germany, 2025

open access: yesEurosurveillance
We report four confirmed autochthonously transmitted gonorrhoea cases in Germany in 2025, with Neisseria gonorrhoeae isolates exhibiting high-level azithromycin and cefixime resistance.
Dagmar Heuer
doaj   +1 more source

Review: Nineteenth-Century British Travelers in the New World, Ed. Christine Devine (UK: Ashgate, 2013)

open access: yesAuthorship, 2013
A review of Christine DeVine, ed., Nineteenth-Century British Travelers in the New World (UK: Ashgate, 2013), 334 pp., £60 hardcover.
Jasper Schelstraete
doaj   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Hepatitis E virus screening in solid organ transplant recipients: prevalence and implications for implementation, Spain, 2021 to 2023

open access: yesEurosurveillance
INTRODUCTION: In solid organ transplant (SOT) recipients, hepatitis E virus (HEV) poses a complex clinical challenge, because there is a risk of developing persistent infection. Current European guidelines recommend the screening of HEV in SOT recipients
Antonio Aguilera
doaj   +1 more source

Introduction: Remix in Retrospect

open access: yesAuthorship, 2013
Introduction to the fourth issue of Authorship.
Jasper Schelstraete
doaj   +2 more sources

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy